Kristopher Brown is a partner in the firm’s Life Sciences group. Mr. Brown negotiates and structures private equity and venture capital financing transactions. He also advises on corporate and transactional matters for numerous financial and corporate strategic investors as well as emerging growth companies in the life sciences, healthcare, financial and technology sectors.

Mr. Brown has experience in the full range of complex commercial transactions, including mergers and acquisitions, divestitures, public offerings, licensing transactions, the formation of investment partnerships, and the creation of strategic and collaborative alliances and joint ventures. Practicing for more than 20 years, Mr. Brown has advised on more than 250 transactions in the life sciences sector alone. In addition, he counsels investors, management executives, and boards of directors on governance and regulation issues and securities law matters.

Mr. Brown is listed as a “Life Sciences Star” and a “U.S. Transactional Rising Star” by LMG Life Sciences and has been listed as a recommended lawyer for life sciences and capital markets: equity and global offerings by The Legal 500, where he was cited as being “highly skilled and committed” and noted for the “strength of his client relationships.”

Prior to joining Goodwin in 2018, Mr. Brown was a partner at Dechert LLP.





Mr. Brown has advised on award-winning life sciences deals, including:

  • Johnson & Johnson in the sale of its BabyCenter business to Everyday Health Group
  • Bicycle Therapeutics in its IPO on Nasdaq in the U.S.
  • Advaxis, Inc. in multiple follow-on financings on Nasdaq
  • Johnson & Johnson in the sale of one of its drug product lines to Baxter
  • Johnson & Johnson in the transfer of collaboration rights and assets to Pharma Mar
  • Johnson & Johnson in its strategic alliance with Apple to deploy the Apple Watch to detect atrial fibrillation
  • Zealand Pharma in the $205 million monetization with Royalty Pharma of Zealand’s diabetes franchise
  • Remedy Pharmaceuticals’ sale to Biogen, in a transaction which received a ”Commended” ranking at the Financial Times North American Innovative Lawyers 2017 Awards*
  • Johnson and Johnson UK Treasury Company Limited as lead investor of the $1.3 billion Series B financing of Grail, Inc., which was named LMG Life Sciences 2017 “Impact Deal of the Year”*
  • Forward Pharma A/S’s IPO on Nasdaq in the U.S., which won M&A Advisor’s “Healthcare/Life Sciences Sector Deal of the Year” award*
  • Johnson & Johnson’s partnership with Verily (f/k/a Google Life Sciences) to innovate advanced surgical robots, which won LMG’s “2015 Collaboration Deal of the Year”*
  • AM-Pharma’s sale of a minority interest in the company to Pfizer Inc. and related option payment, which was a finalist for the 2015 Scrip Awards*
  • Zealand Pharma’s monetization of certain royalty rights under its license agreement with Sanofi-Aventis, which was also a finalist for the 2015 Scrip Awards*

In addition, Mr. Brown advised e-commerce company Lazada Group on the $1 billion sale of a controlling stake in the company to Alibaba, which was named “M&A Deal of the Year: Southeast Asia” at The Asian Lawyer’s 2017 Asia Legal Awards.*

* Denotes experience prior to joining Goodwin.

Professional Activities

Mr. Brown is a member of the American Bar Association and the Association of the Bar of the City of New York.

Professional Experience

Mr. Brown is a member of Brown University’s Advisory Council on Entrepreneurship, and is also a member of the National Advisory Council for, and served until 2018 as the pro bono outside general counsel to In addition, Mr. Brown serves on the investor board of Venture for America, the advisory board of Lyfebulb, as a Blueprint Health mentor, and as a member of the Nordic Mentor Network for Entrepreneurship, or NOME.

In The News









J.D., 1992
Boston University School of Law

(magna cum laude)

A.B., 1989
Brown University

(magna cum laude, Phi Beta Kappa)



New York


U.S. District Court for the Southern District of New York
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique